You are here Home Guidance and resources Resources International scientific guidelines adopted in Australia International scientific guideline: Treatment and prophylaxis of respiratory syncytial virus (RSV) disease EMA/CHMP/257022/2017 adopted by the Therapeutic Goods Administration (TGA) Listen Print Share LinkedIn (Twitter) Facebook Email Loading... About this guideline TGA adopted date: 28 Feb 2020 Overseas effective date: 1 May 2019 Categories: Multidisciplinary | Vaccines (multidisciplinary) Access this international scientific guideline For more information see International scientific guidelines adopted in Australia. Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.